NDC 58005-170-52 - AMCALCILYTE FORTE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58005-170
- Requested NDC
- 58005-170-52
- Package NDCs from labels
- 58005-170-52
- Manufacturer
- Sparhawk Laboratories, Inc.
- Effective date
- 2017-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMCALCILYTE FORTE | Sparhawk Laboratories, Inc. | 2017-02-06 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58005-170-52 | AMCALCILYTE FORTE | 1000 mL in 1 BOTTLE | SOLUTION | 1000 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules India Ltd | 60285a8d-bcb0-40ba-b359-df5c89480cd6 | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Granules India Ltd | 113c031c-6de3-4497-a57d-9740b1ce08ac | 2026-10-07 | Warnings, Adverse reactions | 660YQ98I10 |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
| Personal CARE Saline Nasal | SODIUM CHLORIDE | Delta Brands Inc. | 5ccaf7a1-6891-eac4-e063-6294a90a829f | 2026-10-02 | Warnings | 451W47IQ8X |
| Potassium Chloride | POTASSIUM CHLORIDE | IPG Pharmaceuticals, Inc. | 5dad0879-0f97-4c7d-98fa-baaed51cd2d8 | 2026-10-01 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | QUAGEN PHARMACEUTICALS LLC | 8fac192f-48ab-4def-9c3a-f1cd50b3e2b7 | 2026-09-29 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose And Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | B. Braun Medical Inc. | 8e6569ce-9714-497f-a94b-c6975c1d76f6 | 2026-09-28 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride Hypertonicity Ophthalmic | SODIUM CHLORIDE | Rugby Laboratories | 7546770d-bc12-44b8-9fe0-fc3f5e1d12d1 | 2026-09-24 | Warnings | 451W47IQ8X |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | American Health Packaging | 7c8dd5b0-db93-430f-8bf8-0318504f744c | 2026-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Sodium Chlorode Hypertonicity Ophthalmic Solution | SODIUM CHLORIDE | Rugby Laboratories | 822d25c0-71b3-421d-b702-4cded0c4ca32 | 2026-09-23 | Warnings | 451W47IQ8X |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | Saptalis Pharmaceuticals, LLC | 483f338e-a164-4c1f-a34e-fef3312cb7ec | 2026-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| BURBLE | SODIUM CHLORIDE | LETS BURBLE, INC. | 17f48d4f-907c-3829-e063-6394a90ab202 | 2026-09-22 | Warnings | 451W47IQ8X |
| HEB Saline | NASAL | HEB | 520e20a3-1e16-4cbd-9da3-948747f4f51d | 2026-09-18 | Warnings | 451W47IQ8X |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | 451W47IQ8X |
| Saline | SALINE | FAMILY DOLLAR SERVICES INC | 7d2acfff-e55b-48b9-9d36-4975563e08ff | 2026-09-17 | Warnings | 451W47IQ8X |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATES | Caplin Steriles Limited | fbbd8380-9848-4862-8c73-2f53fcdf7120 | 2026-09-17 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Potassium chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | c2028705-9e5b-424b-983a-1c7a71dedd74 | 2026-09-16 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9b26cc41-3725-4ef1-afdf-5992816d3b0d | 2026-09-16 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | REMEDYREPACK INC. | d1e55181-6f85-42c9-922c-808494b6399a | 2026-09-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | e2638b45-1141-4391-971d-c0dea825e41c | 2026-09-11 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.